|
GTX12134
|
GeneTex International Corporation
|
IKB alpha [6A920], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
FACS, ICC/IF, IHC-P, IP, WB, MS
|
|
|
GTX12139
|
GeneTex International Corporation
|
IKK beta [10AG2], Mouse Monoclonal Antibody
|
Human, Mouse
|
FACS, ICC/IF, IHC-P, IP, WB, MS
|
|
|
GTX13594
|
GeneTex International Corporation
|
NFkB p65 [112A1021], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
FACS, IHC-P, WB, MS
|
|
|
GTX48152-PRO
|
GeneTex International Corporation
|
Human PEX19 protein
|
|
ELISA, WB, MS
|
|
|
P-2017-24
|
Epigentek Group Inc
|
EpiQuik Methyl-CpG Binding Domain Protein 2 ChIP Kit [24 reactions]
|
|
IP
|
|
|
P-2017-48
|
Epigentek Group Inc
|
EpiQuik Methyl-CpG Binding Domain Protein 2 ChIP Kit [48 reactions]
|
|
IP
|
|
|
P-1008-1
|
Epigentek Group Inc
|
Methylamp 96 DNA Modification Kit [96 samples]
|
|
Sample Modification
|
|
|
P-1010-1
|
Epigentek Group Inc
|
Methylamp One-Step DNA Modification Kit [40 samples]
|
|
Sample Modification
|
|
|
P-1010-2
|
Epigentek Group Inc
|
Methylamp One-Step DNA Modification Kit [80 samples]
|
|
Sample Modification
|
|
|
P-9003-050
|
Epigentek Group Inc
|
Methylamp RNA Bisulfite Conversion Kit [50 reactions]
|
|
Sample Modification
|
|
|
P-1011-1
|
Epigentek Group Inc
|
Methylamp Universal Methylated DNA Kit [10 modifications]
|
|
Sample Modification
|
|
|
P-1011-2
|
Epigentek Group Inc
|
Methylamp Universal Methylated DNA Kit [20 modifications]
|
|
Sample Modification
|
|
|
P-1016-40
|
Epigentek Group Inc
|
Methylamp Whole Cell Bisulfite Modification Kit [40 samples]
|
|
Sample Modification
|
|
|
P-1016-80
|
Epigentek Group Inc
|
Methylamp Whole Cell Bisulfite Modification Kit [80 samples]
|
|
Sample Modification
|
|
|
HY-123023-25ug
|
MedChemexpress LLC
|
12(S)-HETE D8 [CAS 84807-90-9]
|
|
|
|
|
HY-140381-100mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-250mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-50mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-10mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-100mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-25mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-5mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-50mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13010-10mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-100mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
